5-Amino-1MQ Tablets are usually made by pressing high-purity (≥ 99%) powder, with a content of 50mg per tablet. They are packaged in dark bottles (such as 30 tablets/bottle) to ensure stability. Some products offer customized specifications (such as 10mg, 20mg) to meet different experimental needs. NNMT is a key regulatory enzyme of cell energy metabolism, and its overexpression is closely related to obesity, diabetes and other metabolic diseases. 5-Amino-1MQ achieves triple regulation by competitively binding to the active center of NNMT. Maintaining NAD ⁺ homeostasis can prevent the conversion of nicotinamide to 1-methylnicotinamide, reduce the pathway of NAD ⁺ consumption, and increase intracellular NAD ⁺ levels by 30% -50%. This effect is particularly significant in senescent cells, partially reversing the trend of NAD ⁺ decreasing with age. It reduces the consumption of methyl donor S-adenosylmethionine (SAM) and promotes epigenetic modification processes such as DNA methylation. Experiments have shown that this compound can restore SAM levels in liver tissue to a youthful state. This substance can inhibit the expression of genes related to adipocyte differentiation, such as PPAR γ and C/EBP α, and reduce the accumulation of white adipose tissue. In a high-fat diet induced obese mouse model, continuous administration for 11 days resulted in a 34% reduction in epididymal fat pad weight.
We not only provide pure powder and capsules, but also other dosage forms. If necessary, please contact our sales team.
Our products from









5-Amino-1MQ COA



Metabolic health is the foundation for maintaining normal physiological functions in the human body, involving the metabolic balance of nutrients such as sugar, fat, and protein. However, changes in modern lifestyles, such as high calorie diet intake, lack of exercise and long-term mental stress, have led to a significant increase in the incidence rate of metabolic diseases, including obesity, diabetes, fatty liver, etc. These diseases not only affect the quality of life of patients, but also increase the risk of serious complications such as cardiovascular disease and cancer. Therefore, finding effective intervention methods to improve metabolic health has become a hot topic in current medical research. 5-Amino-1MQ (NNMTi), as a novel inhibitor of nicotinamide N-methyltransferase (NNMT), has attracted widespread attention in the field of metabolic research in recent years. It demonstrates potential application value in regulating energy metabolism, improving insulin sensitivity, and reducing fat accumulation through unique biological mechanisms.
Mechanism of 5-Amino-1MQ Tablets in Improving Metabolic Health
Promote fat reduction and energy expenditure
White adipose tissue (WAT) is the main fat storage organ in the human body, and its excessive accumulation is a core characteristic of obesity. Research has shown that 5-Amino-1MQ can reduce the differentiation and proliferation of adipocytes in WAT by inhibiting NNMT activity, while promoting the expression of fat breakdown related genes such as hormone sensitive lipase (HSL) and adipose triglyceride lipase (ATGL), thereby accelerating fat mobilization and utilization.In animal experiments, after treatment with 5-Amino-1MQ in obese mice, their WAT mass significantly decreased, adipocyte volume decreased, and serum free fatty acid levels increased, indicating enhanced fat breakdown. In addition, 5-Amino-1MQ can also improve insulin resistance and further promote the balance of fat metabolism by regulating the inflammatory response in adipose tissue.

Enhance energy consumption and heat generation

In addition to reducing fat storage, 5-Amino-1MQ can also increase the body's energy expenditure by activating the thermogenic function of brown adipose tissue (BAT) and beige adipocytes. BAT is a type of adipose tissue specifically designed for thermogenesis, rich in mitochondria and uncoupling protein 1 (UCP1), which can convert chemical energy into thermal energy without producing ATP. Beige adipocytes are transformed from WAT under specific stimuli and have similar thermogenic functions.5-Amino-1MQ Tablets promotes the activation of BAT and beige adipocytes by upregulating the expression of thermogenic genes such as UCP1, thereby increasing the body's resting energy expenditure. In animal experiments, mice treated with 5-Amino-1MQ showed higher thermogenesis and core body temperature under cold exposure conditions, and their weight gain was significantly lower than that of the control group, further confirming its role in enhancing energy expenditure.
Improving glucose homeostasis and insulin sensitivity
The maintenance of glucose homeostasis depends on insulin mediated glucose uptake and utilization. In insulin resistance, target tissues such as muscles, fat, and liver have reduced sensitivity to insulin, leading to decreased glucose uptake and elevated blood sugar levels. 5-Amino-1MQ enhances the response of target tissues to insulin by improving the insulin signaling pathway, thereby promoting glucose uptake and utilization.
Research has shown that 5-Amino-1MQ can upregulate the phosphorylation levels of insulin receptor (IR) and insulin receptor substrate (IRS), activate the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway, and promote the translocation of glucose transporter 4 (GLUT4) and glucose uptake. In animal experiments, high-fat diet induced obese mice treated with 5-Amino-1MQ showed a significant increase in GLUT4 expression in muscle and adipose tissue, and a significant decrease in blood glucose levels.

Inhibit hepatic glucose output

The liver is an important organ for regulating blood glucose levels, and increased hepatic glucose output during fasting or insulin resistance is one of the main causes of hyperglycemia. 5-Amino-1MQ reduces hepatic glucose production and output by inhibiting the expression of gluconeogenesis related genes in the liver, such as phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), thereby lowering blood glucose levels.
In animal experiments, mice treated with 5-Amino-1MQ showed significantly lower serum glucose levels than the control group under fasting conditions, and the activity of gluconeogenic enzymes in the liver was inhibited. In addition, 5-Amino-1MQ can further inhibit hepatic glucose output and maintain glucose homeostasis by improving liver insulin sensitivity.
Regulating lipid metabolism and preventing fatty liver

Reduce serum lipid levels
Hyperlipidemia is one of the important characteristics of metabolic syndrome, closely related to the occurrence of cardiovascular disease. 5-Amino-1MQ reduces the levels of triglycerides (TG) and low-density lipoprotein cholesterol (LDL-C) in serum by regulating the expression of lipid metabolism related genes, while increasing the level of high-density lipoprotein cholesterol (HDL-C), thereby improving lipid metabolism disorders.Research has shown that 5-Amino-1MQ can inhibit the activity of fatty acid synthase (FAS) and acetyl CoA carboxylase (ACC) in the liver, reducing the synthesis of fatty acids; Simultaneously promoting the expression of genes related to fatty acid oxidation, such as carnitine palmitoyltransferase 1 (CPT1) and peroxisome proliferator activated receptor alpha (PPAR alpha), enhances the oxidative utilization of fatty acids. In animal experiments, high-fat diet induced obese mice treated with 5-Amino-1MQ showed a significant decrease in serum TG and LDL-C levels, an increase in HDL-C levels, and a significant improvement in lipid metabolism.
Preventing non-alcoholic fatty liver disease (NAFLD)
NAFLD is a chronic liver disease closely related to metabolic syndrome, characterized by excessive accumulation of fat in liver cells. 5-Amino-1MQ prevents the occurrence and development of NAFLD by reducing the synthesis and accumulation of fat in the liver, inhibiting inflammatory reactions and fibrosis processes.
In animal experiments, high-fat diet induced NAFLD mice treated with 5-Amino-1MQ showed a significant reduction in liver steatosis and decreased levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicating improved liver function. In addition, 5-Amino-1MQ can further protect liver health by regulating the balance of gut microbiota, reducing the production of endotoxins and liver inflammation.

Regulating NAD ⁺ metabolism and delaying aging

The role of NAD ⁺ in metabolic health
NAD ⁺ is an important coenzyme that participates in various metabolic reactions within cells, including glycolysis, tricarboxylic acid cycle, and oxidative phosphorylation. In addition, NAD ⁺ is also a substrate for Sirtuins family proteins (deacetylases) and poly (ADP ribose) polymerase (PARP), playing an important role in regulating gene expression, DNA repair, and cellular aging processes.
As age increases, the level of intracellular NAD ⁺ gradually decreases, leading to decreased metabolic function and the occurrence of age-related diseases. Therefore, maintaining the steady state of NAD ⁺ is of great significance for improving metabolic health and delaying aging.
The regulatory effect of 5-Amino-1MQ on NAD ⁺ metabolism
5-Amino-1MQ increases the accumulation of NAD ⁺ precursors (such as nicotinamide mononucleotide, NMN) in cells by inhibiting NNMT activity and reducing the consumption of nicotinamide methylation. In addition, 5-Amino-1MQ can further promote the generation of NAD ⁺ by activating the expression of NAD ⁺ synthesis related enzymes, such as nicotinamide phosphoribosyltransferase (NAMPT).
In animal experiments, aged mice treated with 5-Amino-1MQ showed significantly increased levels of NAD ⁺ in liver, muscle, and brain tissues, enhanced activity of Sirtuins family proteins, improved metabolic function, and delayed aging phenotype. For example, mice have improved glucose tolerance, insulin sensitivity, exercise endurance, and cognitive function.

Potential clinical application directions
Based on the results of preclinical studies, 5-Amino-1MQ Tablets have potential application value in the following clinical fields:
Obesity treatment
Obesity is a global public health issue, and its treatment still faces many challenges. 5-Amino-1MQ provides a new strategy for obesity treatment by promoting fat reduction and energy expenditure. Compared with traditional weight loss drugs, the mechanism of action of 5-Amino-1MQ is more unique and has fewer side effects, making it a safe and effective weight loss drug.
Diabetes management
Diabetes is a metabolic disease characterized by hyperglycemia. its occurrence is closely related to insulin resistance and pancreatic beta cell failure. 5-Amino-1MQ contributes to the management of diabetes by improving glucose homeostasis and insulin sensitivity. Especially for patients with type 2 diabetes, 5-Amino-1MQ may be used as an auxiliary treatment drug in combination with existing hypoglycemic drugs to improve the treatment effect.
Intervention for metabolic syndrome
Metabolic syndrome is a group of metabolic disorders characterized by obesity, hypertension, hyperglycemia, and lipid metabolism disorders, and its occurrence is closely related to insulin resistance. 5-Amino-1MQ can comprehensively improve various indicators of metabolic syndrome by regulating multiple metabolic pathways, providing a new means of intervention for metabolic syndrome.
Anti aging and health promotion
With the intensification of population aging, anti-aging and health promotion have become important directions in current medical research. 5-Amino-1MQ can delay cellular aging, improve metabolic function, and enhance quality of life by regulating NAD ⁺ metabolism and activating Sirtuins family proteins. Therefore, 5-Amino-1MQ may serve as an anti-aging drug for the prevention and treatment of age-related diseases.
Hot Tags: 5-amino-1mq tablets, China 5-amino-1mq tablets manufacturers, suppliers, salcatonin injection, intranasal desmopressin acetate, best glp 1 peptide, IGF 1 LR3 Cream, glp1 shot, etelcalcetide structure

